Intelect® RPW
19
Before a treatment with Radial Pressure Wave, a correct examination
and diagnosis should be performed. Stay current with the latest
developments and medical publications on Radial Pressure Wave
therapy for details on contraindications and side effects not
known at the time of manufacturing. The Intelect RPW unit is
contraindicated for the following:
•
Do not use Radial Pressure Wave treatment on any body part
during pregnancy.
•
Over the pregnant or potentially pregnant uterus. Therefore,
radial pressure wave treatment should not be applied over
the uterus unless specific assurance can be attained from the
patient that she is not pregnant.
•
Haemophilia, or other coagulation disorders.
•
Anticoagulant pharmaceuticals, especially Marcumar.
•
Acute inflammations. Do not use over swollen, inflamed,
infected tissue, skin eruptions or on other acute tissue lesions.
•
Polyneuropathy area. A Diabetes patient often obtains
disturbed sensory and nervous function in the
polyneuropathic area.
•
Cortisone therapy: Wait minimum 6 weeks after local
cortisone injection before treatment with radial pressure
waves.
•
Patients with hemorrhages or risk of hemorrhage.
•
Patients with malignant tumors and undiagnosed tumors.
•
Swellings that still feel warm.
•
Implants, areas where implants have been removed,
damaged implants, and metal inclusions.
•
Over superficial endoprosthesis or metal implants.
•
Severe arterial obstructions (stage III and IV).
•
Gynecological disorders involving acute inflammation.
•
Deep vein thrombosis, phlebitis, varices.
•
Arterial disease, circulatory insufficiency.
•
Over eyes.
•
Over reproductive organs.
•
Over cardiac pacemakers and defibrillators, cochlear implants,
bone growth stimulators, deep brain stimulators, spinal cord
stimulators, and other nerve stimulators.
•
Over open lamina (after laminectomy; spina bifida).
•
Directly over the carotid sinuses, ceruical stellate ganglion, or
Vagus nerve located in the anterior neck triangle.
•
Direct application over cancerous tumors or lesions due to its
potential to increase blood flow to the area of malignancy.
•
Neoplastic tissues or space occupying lesions.
GENERAL
